Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pidotimod as adjunctive therapy for recurrent urinary tract infection
CTR20200104Phase 4Completed
- Sponsor
- New Journey Wansheng Pharmaceutical
- Start
- Jan 2020
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of pidotimod in urinary tract infection (UTI), sponsored by New Journey Wansheng Pharmaceutical. Started Jan 2020; status: completed.
02
Drugs
pidotimod
03
Conditions
urinary tract infection (UTI)
Beyond the preview
Go deeper on CTR20200104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200104.